153 related articles for article (PubMed ID: 35643351)
1. Natural Killer Cell Alloreactivity Predicted By Killer Cell Immunoglobulin-Like Receptor Ligand Mismatch Does Not Impact Engraftment in Umbilical Cord Blood and Haploidentical Stem Cell Transplantation.
Otegbeye F; Vina MAF; Wang T; Bolon YT; Lazaryan A; Beitinjaneh A; Bhatt VR; Castillo P; Marsh SGE; Hildebrandt GC; Assal A; Brown VI; Hsu J; Spellman S; de Lima M; Lee SJ
Transplant Cell Ther; 2022 Aug; 28(8):483.e1-483.e7. PubMed ID: 35643351
[TBL] [Abstract][Full Text] [Related]
2. Interrogating the impact of KIR ligand mismatch in engraftment following HLA-disparate stem cell transplantation.
Li L; Kolk M; Fernandez-Vina M; de Lima M; Otegbeye F
Bone Marrow Transplant; 2020 Dec; 55(12):2294-2297. PubMed ID: 32461586
[TBL] [Abstract][Full Text] [Related]
3. Negative Impact of Unidirectional Host-versus-Graft Killer Cell Immunoglobulin-like Receptor Ligand Mismatch on Transplantation Outcomes after Unmanipulated Haploidentical Peripheral Blood Stem Cell Transplantation for Acute Myeloid Leukemia.
Yahng SA; Jeon YW; Yoon JH; Shin SH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Kim HJ
Biol Blood Marrow Transplant; 2016 Feb; 22(2):316-323. PubMed ID: 26415557
[TBL] [Abstract][Full Text] [Related]
4. Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide.
Shimoni A; Labopin M; Lorentino F; Van Lint MT; Koc Y; Gülbas Z; Tischer J; Bruno B; Blaise D; Pioltelli P; Afanasyev B; Ciceri F; Mohty M; Nagler A
Leukemia; 2019 Jan; 33(1):230-239. PubMed ID: 29907809
[TBL] [Abstract][Full Text] [Related]
5. Impact of KIR-ligand mismatch on pediatric T-cell acute lymphoblastic leukemia in unrelated cord blood transplantation.
Kawahara Y; Ishimaru S; Tanaka J; Kako S; Hirayama M; Kanaya M; Ishida H; Sato M; Kobayashi R; Kato M; Goi K; Saito S; Koga Y; Hashii Y; Kato K; Sato A; Atsuta Y; Sakaguchi H
Transplant Cell Ther; 2022 Sep; 28(9):598.e1-598.e8. PubMed ID: 35660064
[TBL] [Abstract][Full Text] [Related]
6. Single Cord Blood Transplantation Versus Unmanipulated Haploidentical Transplantation for Adults with Acute Myeloid Leukemia in Complete Remission.
Konuma T; Kanda J; Yamasaki S; Harada K; Shimomura Y; Terakura S; Mizuno S; Uchida N; Tanaka M; Doki N; Ozawa Y; Nakamae H; Sawa M; Matsuoka KI; Morishige S; Maruyama Y; Ikegame K; Kimura T; Kanda Y; Ichinohe T; Atsuta Y; Yanada M
Transplant Cell Ther; 2021 Apr; 27(4):334.e1-334.e11. PubMed ID: 33836881
[TBL] [Abstract][Full Text] [Related]
7. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
Farag SS; Bacigalupo A; Eapen M; Hurley C; Dupont B; Caligiuri MA; Boudreau C; Nelson G; Oudshoorn M; van Rood J; Velardi A; Maiers M; Setterholm M; Confer D; Posch PE; Anasetti C; Kamani N; Miller JS; Weisdorf D; Davies SM;
Biol Blood Marrow Transplant; 2006 Aug; 12(8):876-84. PubMed ID: 16864058
[TBL] [Abstract][Full Text] [Related]
8. Impact of Natural Killer Cell-Associated Factors on Acute Leukemia Outcomes after Haploidentical Hematopoietic Stem Cell Transplantation with αβ T Cell Depletion in a Pediatric Cohort.
Glushkova S; Shelikhova L; Voronin K; Pershin D; Vedmedskaya V; Muzalevskii Y; Kazachenok A; Kurnikova E; Radygina S; Ilushina M; Khismatullina R; Maschan A; Maschan M
Transplant Cell Ther; 2024 Apr; 30(4):435.e1-435.e12. PubMed ID: 38278183
[TBL] [Abstract][Full Text] [Related]
9. NK cell recovery, chimerism, function, and recognition in recipients of haploidentical hematopoietic cell transplantation following nonmyeloablative conditioning using a humanized anti-CD2 mAb, Medi-507.
Koenecke C; Shaffer J; Alexander SI; Preffer F; Dombkowski D; Saidman SL; Dey B; McAfee S; Spitzer TR; Sykes M
Exp Hematol; 2003 Oct; 31(10):911-23. PubMed ID: 14550807
[TBL] [Abstract][Full Text] [Related]
10. Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome.
Childs RW; Tian X; Vo P; Purev E; Kotecha RR; Carlsten M; Clara J; Flegel WA; Adams SD; Khuu HM; Stroncek DF; Cook L; Worthy T; Geller NL; Wells B; Wilder J; Reger R; Aue G
Br J Haematol; 2021 Jun; 193(5):951-960. PubMed ID: 33993466
[TBL] [Abstract][Full Text] [Related]
11. Association of iKIR-mismatch model and donor aKIRs with better outcome in haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia.
Zhang Y; Ye C; Zhu H; Zhuang Y; Chen S; Weng Y; Ren J; Luo X; Zheng J; Zheng X; Li J; Lan L; Xie Y; Han Z; Hu J; Yang T
Front Immunol; 2022; 13():1091188. PubMed ID: 36761162
[TBL] [Abstract][Full Text] [Related]
12. Is there an impact of killer cell immunoglobulin-like receptors and KIR-ligand incompatibilities on outcomes after unrelated cord blood stem cell transplantation?
Willemze R; Ruggeri A; Purtill D; Rodrigues CA; Gluckman E; Rocha V;
Best Pract Res Clin Haematol; 2010 Jun; 23(2):283-90. PubMed ID: 20837340
[TBL] [Abstract][Full Text] [Related]
13. Number of HLA-Mismatched Eplets Is Not Associated with Major Outcomes in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: A Center for International Blood and Marrow Transplant Research Study.
Zou J; Wang T; He M; Bolon YT; Gadalla SM; Marsh SGE; Kuxhausen M; Gale RP; Sharma A; Assal A; Prestidge T; Aljurf M; Cerny J; Paczesny S; Spellman SR; Lee SJ; Ciurea SO
Transplant Cell Ther; 2022 Feb; 28(2):107.e1-107.e8. PubMed ID: 34774819
[TBL] [Abstract][Full Text] [Related]
14. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
Sahin U; Dalva K; Gungor F; Ustun C; Beksac M
Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
[TBL] [Abstract][Full Text] [Related]
15. KIR-ligand mismatch in allogeneic hematopoietic stem cell transplantation.
Malmberg KJ; Schaffer M; Ringdén O; Remberger M; Ljunggren HG
Mol Immunol; 2005 Feb; 42(4):531-4. PubMed ID: 15607809
[TBL] [Abstract][Full Text] [Related]
16. Killer Cell Immunoglobulin-Like Receptor-Ligand Mismatch in Donor versus Recipient Direction Provides Better Graft-versus-Tumor Effect in Patients with Hematologic Malignancies Undergoing Allogeneic T Cell-Replete Haploidentical Transplantation Followed by Post-Transplant Cyclophosphamide.
Wanquet A; Bramanti S; Harbi S; Fürst S; Legrand F; Faucher C; Granata A; Calmels B; Lemarie C; Picard C; Chabannon C; Weiller PJ; Castagna L; Blaise D; Devillier R
Biol Blood Marrow Transplant; 2018 Mar; 24(3):549-554. PubMed ID: 29247781
[TBL] [Abstract][Full Text] [Related]
17. The importance of natural killer cell killer immunoglobulin-like receptor-mismatch in transplant outcomes.
Stringaris K; Barrett AJ
Curr Opin Hematol; 2017 Nov; 24(6):489-495. PubMed ID: 28817402
[TBL] [Abstract][Full Text] [Related]
18. Effects of KIR ligand incompatibility on clinical outcomes of umbilical cord blood transplantation without ATG for acute leukemia in complete remission.
Tanaka J; Morishima Y; Takahashi Y; Yabe T; Oba K; Takahashi S; Taniguchi S; Ogawa H; Onishi Y; Miyamura K; Kanamori H; Aotsuka N; Kato K; Kato S; Atsuta Y; Kanda Y
Blood Cancer J; 2013 Nov; 3(11):e164. PubMed ID: 24292416
[TBL] [Abstract][Full Text] [Related]
19. Selecting the Best Donor for Haploidentical Transplant: Impact of HLA, Killer Cell Immunoglobulin-Like Receptor Genotyping, and Other Clinical Variables.
Solomon SR; Aubrey MT; Zhang X; Piluso A; Freed BM; Brown S; Jackson KC; Morris LE; Holland HK; Solh MM; Bashey A
Biol Blood Marrow Transplant; 2018 Apr; 24(4):789-798. PubMed ID: 29355721
[TBL] [Abstract][Full Text] [Related]
20. Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation.
Symons HJ; Leffell MS; Rossiter ND; Zahurak M; Jones RJ; Fuchs EJ
Biol Blood Marrow Transplant; 2010 Apr; 16(4):533-42. PubMed ID: 19961944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]